Navigation Links
Novadaq Resumes Normal Business Operations by Securing ICG for SPY
Date:10/4/2007

Akorn Receives Approval for Alternate ICG Manufacturing Site

TORONTO, Oct. 4 /PRNewswire-FirstCall/ - Novadaq(R) Technologies Inc. (TSX: NDQ), a developer of real-time medical imaging systems and image guided therapies for the operating room, today announced has received a sufficient supply of ICG to immediately resume normal business operations. Akorn, Inc. (Buffalo Grove, Ill) currently the exclusive suppliers of indocyanine green (ICG) in the United States (US) announced on September 26, 2007 that they had have received a long awaited approval for their alternate ICG manufacturing site from the US Food and Drug Administration (FDA). The approval resolves all issues related to the short supply of ICG, which has adversely affected all users of ICG since March of 2007.

"As expected, the time it took to secure the new supply of ICG did break some of our momentum. Some of our customers chose to wait to place orders until the new ICG was introduced," said Dr. Arun Menawat, President and CEO. "However, now that we have resumed our normal operations our sales team is executing on the pipeline of new potential installs and I am pleased with their progress".

Novadaq understands that a second supplier of ICG plans to enter the US market before the end of 2007 which should further reduce the future risk of short supply. Novadaq's policy is to where ever possible secure more than one supplier for any of its products such as the SPY System, where two suppliers are qualified and currently able to deliver devices.

About Novadaq Technologies

Novadaq Technologies Inc. (TSX: NDQ) develops and commercializes medical imaging systems and real-time image guided therapies for use in the operating room. Novadaq's proprietary ICG imaging systems can be used to visualize blood vessels, nerves and the lymphatic system during a variety of surgical procedures. Novadaq's SPY(R) Imaging System, commercially available worldwide, enables cardiac surgeons
'/>"/>

SOURCE Novadaq Technologies Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. ‘Bird flu-free’ India resumes egg expors
2. Obese children may have abnormalities of lipoproteins
3. Inflammatory bowel disease linked to genetic abnormality
4. Anti-Cancer Drug Restores Normal Cell Growth
5. Dyslexia due to cerebellum abnormality
6. Cleft lip and palate are due to abnormality in brain structure
7. Early Detection Of Facial Abnormalities in a Fetus
8. Abnormal Brain Structure One Of The Reasons For Depression in Adolescents
9. Antidepressants Could Lead To Abnormal Bleeding
10. Test for prenatal chromosomal abnormalities using cervical swab
11. People with abnormal heart rhythms must avoid fish oil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/9/2009)...re/ -- , - New Online Service Provides the ...s at Whatever Age , A new website has been ...esigned specifically to get rid of all examination...AID and it can be found at, http://www.befreefrom...struction, there and then, on how to get rid of ex...
(Date:1/8/2009)...art risk may not be accurate in some cases , ...udies, from the United States and the Netherlands,...lished Framingham Risk Score in predicting heart d...am score, based on findings of a decades-long stud...to assess risk on the basis of seven factors: age,...
(Date:1/8/2009)...rganizations offers five action steps to improve r...wswire/ -- Despite the recent three-hour cease fir...ies to residents of the Palestinian territory, upw...clean water and medical help. U.S.-based internati... region see this arrangement to allow sporadic del...
(Date:1/8/2009)... Daschle at his confirmation hearing to be the nex..., WASHINGTON, Jan. 8 Bi... Senator Tom Daschle, nominee for Department of He...by fellow BPC founder and friend Senator Bob Dole ... convened by the Senate Health, Education, Labor, ...
Breaking Medicine News(10 mins):Health News:Be Free From Exam Nerves 2Health News:Studies Challenge Framingham Risk Score 2Health News:Studies Challenge Framingham Risk Score 3Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4
...can reduce infant mortality rates, the Centre has ...mpaigns on breast feeding on the lines of the init...alone can reduce infant mortality rates by 13 per ...r the child but also ensures a strong foundation f...
...the Bhopal Gas Tragedy continuesto haunt the publi...six more victims dead from the 1984 Bhopal gas tra...re to treat the affectedpeople are being accused o...e than six people have died in the past two months...
... called NFATc1 tends to cause massive bone accumul...osis //- HHMI investigator Gerald Crabtree and HHM...rtebrates, bone is constantly being formed and bei...lled osteoclasts continuously degrade bone, while ...
...he issue of Archives of General Psychiatry, it is ...der the age of 20, being treated with antipsychoti...cs are medications used to treat mental disorders,...may involve loss of contact with reality. Several ...
Other Medicine News:Health News:Six More Bhopal Gas Tragedy Continues to Take Toll 2Health News:Osteoporosis – A New Treatmen 2Health News:Osteoporosis – A New Treatmen 3Health News:Number of Children, Teens Being Treated for Mental Disorders is on Rise 2
(Date:1/8/2009)...to Identify and Validate Novel Gene Expression Bio...Gene Expression Platform , , FREMONT, Calif., J...s, Inc. (OTC Bulletin Board: WGBS), a leading deve...ing, cell biology and stem cell research systems, ...ation with the University of Texas Southwestern M...
(Date:1/8/2009)... at the initial dose in an ongoing Phase Ib trial ... after three days , , Conference Call Today at ...irstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq:...ohort of an ongoing Phase Ib clinical trial of ANA...polymerase inhibitor. ANA598 was very well-tolera...
(Date:1/7/2009)...ants Drive the Increase , , WHITE PLAINS, N.Y.,...statistics confirm that the decades-long rise in t...ting more infants than ever at increased risk of d...s. , , Nearly 543,000 babies were born too soon...lth Statistics, which today released "Births: Fina...
(Date:1/7/2009)... Tiantan Puhua Hospital Stem Cells ...dwide leader in using stem cells to effectively tr...w globally experienced additions to its medical an...pital,s treatment capabilities for growing numbers...r doctors include the distinguished Dr. Jiang Ping...
Breaking Medicine Technology:WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Preterm Births Rise 36 Percent Since Early 1980s 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Male cyclists risk sexual problems if they don 26 23146 3Bt choose the right bike 3937 1Male cyclists risk sexual problems if they don 26 23146 3Bt choose the right bike 3937 2Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 1Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 2Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 3Johnson 26 Johnson to Host Analyst Conference Call on Second Quarter Results 23454 1RADI Medical Systems Launches Next Generation PressureWire 28R 29 Certus 6415 1RADI Medical Systems Launches Next Generation PressureWire 28R 29 Certus 6415 2
...l results from a,Phase II study presented for the ...annual meeting showed that MK-0974, an,investigati...eceptor antagonist, significantly improved migrain...lacebo, and the relief was,sustained through 24 ho...tudy. Responses specific to other measures, such a...
...irstCall/ --,Mymetics Corporation announced today ...,s HIV vaccine elicited neutralizing,IgA mucosal a...A,antibodies are considered as a possible first li...ere presented by Sylvain,Fleury, Ph.D., Mymetics, ...titled, "Without Mucosal Adjuvant, Virosomes-gp41,...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 2Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 3Mymetics' HIV Vaccine Demonstrates First-Ever Production of,Neutralizing IgA Antibodies in Non-Human Primate Model 4
Fixed chair back and armrests, electric lift with 8" (20.3cm) stroke, foot pedal control, choice of upholstery colors. Optional features: 15 tilt mechanism and footrest, locking rotation, sliding arm
Complete with headrest, armrests, footrest and foot switch.
...Large hinged footstep can support patient's full w...ired. Hydraulic base. Patients may be raised and l...chair back or optional corded foot switch. Dual ro... to swivel the chair 330 without changing position...
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles.
Medicine Products: